Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass

Journal of Cardiovascular Surgery

Volumn 43, Issue 4, 2002, Pages 437-440

  Sugita, T ^a   Watarida, S ^a   Katsuyama, K ^a   Nakajima, Y ^a   Yamamoto, R ^a   Mori, A ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

Cardiopulmonary bypass; Child; Glycoproteins; Protease inhibitors

Indexed keywords

ANESTHETIC AGENT; BETAMETHASONE; FENTANYL CITRATE; HEPARIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MANNITOL; NEUROMUSCULAR BLOCKING AGENT; PROTAMINE; PROTEINASE INHIBITOR; ULINASTATIN;

AORTA CLAMPING; ARTERIAL BLOOD; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LUNG ALVEOLUS OXYGEN TENSION; LUNG FUNCTION; MALE; OPERATION DURATION; PROSPECTIVE STUDY; RANDOMIZATION; TIME;

CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; FEMALE; GLYCOPROTEINS; HEART DEFECTS, CONGENITAL; HUMANS; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; PROSPECTIVE STUDIES; RESPIRATION; TRYPSIN INHIBITORS;

EID: 0036696056     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993;105:25-30.
2. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliot M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105:234-41.
3. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-16.
4. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108: 636-41.
5. Kawahito K, Kawakami M, Fujiwara T, Adachi H, Ino T. Interleukin-8 and monocyte chemotactic activating factor responses to cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;110:99-102.
6. Naldini A, Borrelli E, Cesari S, Giomarelli P, Toscano M. In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary bypass. Cytokine 1995;2:165-70.
7. Steinberg BM, Grossi EA, Schwarts DS, McLoughlin DE, Aguinaga M, Bizekis C et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995;60:525-9.
8. Kunkel SL, Standiford T, Kasahara K, Striter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17-23.
9. Zwahlen R, Waltz A, Rot A. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int Rev Exp Pathol 1993;34:27-42.
10. Biffl WL, Moore EE, More FA, Carl VS, Franciose RJ, Banerjee A. Interleukin-8 increases endothelial permeability independent of neutrophils. J Trauma 1995;39:98-103.
11. Sugita T, Watarida S, Katsuyama K, Nakajima Y, Yamamoto R, Mori A. Interleukin 8 concentration and its effect on respiratory function in pediatric patients undergoing cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 1997;3:187-90.
12. Endo S, Inada K, Yamashita H, Takakuwa T, Nakae H, Yamada Y et al. The inhibitory actions of protease inhibitors on the production of polymorphonuclear leukocyte elastase and interleukin-8. Res Commun Chem Pathol Pharmacol 1993;82:27-34.
13. Kawamura T, Inada K, Akasako N, Wakusawa R. Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery. Can J Anaesth 1996;43:456-60.
14. Hiyama A, Takeda J, Kotake Y, Morisaki H, Fukushima K. A human urinary protease inhibitor (Ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass. J Cardiothorac Vasc Anaesth 1997;11:580-4.
15. Ida N, Sakurai S, Hosoki K, Kunitomo T. A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids. J Immunol Methods 1992;156:27-38.
16. Ida N, Sakurai S, Kawano G. Detection of monocyte chemotactic and activating factor (MCAF) in normal blood and urine using a sensitive ELISA. Cytokine 1994;6:32-9.
17. Neumann S, Jochum M. Elastase-α1-proteinase inhibitor complex. Methods of enzymatic analysis. In: Bergmeyer HU, editor. 3rd edition. Wenheim, Deerfield Beach, Florida, Basel: Verlag Chemie, 1984:184-95.
18. Cao Z, Okazalci Y, Naito K, Ueno T, Natsuaki M, Itoh T. Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart. Ann Thorac Surg 2000;69:1121-6.
19. Binns OA, Delima NF, Buchanan SA, Mauney MC, Cope JT, Thies SD et al. Neutrophil endopeptidase inhibitor improves pulmonary function during reperfusion after 18-hour preservation. J Thorac Cardiovasc Surg 1996;112:607-13.
20. Hiyama A, Takeda J, Kotake Y, Morisaki H, Fukushima K. A human urinary protease inhibitor (Ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997;11:580-4.
21. Kirklin JW, Barrat-Boyes BG. Postoperative care. In: Kirklin JW, Barrat-Boyes BG, editors. Cardiac surgery. New York: Wiley, 1993:195-248.
22. Gillinov AM, Redmond JM, Winkelstein JA, Zehr KJ, Herskowitz A, Baumgartner WA et al. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. Ann Thorac Surg 1994;57:345-52.
23. Gillinov AM, Redmond JM, Zehr KJ, Wilson IC, Curtis WE, Bator JM et al. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg 1994;57:126-33.
24. Tonz M, Mihaljevic T, von-Segesser LK, Fehr J, Schmid ER, Turina MI. Acute lung injury during cardiopulmonary bypass: are the neutrophils responsible? Chest 1995;108:1551-6.
25. Raijmakers PG, Groeneveld AB, Rauwerda JA, Schneider AJ, Teule GJ, Hack CE et al. Transinet increase in Interleukin-8 and pulmonary microvascular permeability following aortic surgery. Am J Respir Crit Care Med 1995;151:698-705.